Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease by Erickson, J, Neidhart, D J, VanDrie, J, Kempf, D J, Wang, X C, Norbeck, D W, Plattner, J J, Rittenhouse, J W, Turon, M, Wideburg, N

Get full text

Characterization of the cell coat of Ehrlich ascites tumor cells by Rittenhouse, Harry G, Rittenhouse, Judith W, Takemoto, Larry

Get full text

Design, Activity, and 2.8 Å Crystal Structure of a C$_2$ Symmetric Inhibitor Complexed to HIV-1 Protease by Erickson, John, Neidhart, David J., VanDrie, John, Kempf, Dale J., Wang, Xiu Chun, Norbeck, Daniel W., Plattner, Jacob J., Rittenhouse, Judith W., Turon, Mary, Wideburg, Norman, Kohlbrenner, William E., Simmer, Robert, Helfrich, Rosalind, Paul, Deborah A., Knigge, Mark

Get full text

Design, activity, and 2.8 angstrom crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease by Erickson, John, Neidhart, David J, VanDrie, John, Kempf, Dale J, Wang, Xiu Chun, Norbeck, Daniel W, Plattner, Jacob J, Rittenhouse, Judith W, Turon, Mary, Wideburg, Norman, Kohlbrenner, William E, Simmer, Robert, Helfrich, Rosalind, Paul, Deborah A, Knigge, Mark

Get full text

pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs by Williams, Timothy K, Costantino, Christina L, Bildzukewicz, Nikolai A, Richards, Nathan G, Rittenhouse, David W, Einstein, Lisa, Cozzitorto, Joseph A, Keen, Judith C, Dasgupta, Abhijit, Gorospe, Myriam, Gonye, Gregory E, Yeo, Charles J, Witkiewicz, Agnieszka K, Brody, Jonathan R

Get full text

Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when psa levels are 2.51 to 4 ng/mL and digital rectal examination is not suspic... by Catalona, William J, Partin, Alan W, Finlay, Judith A, Chan, Daniel W, Rittenhouse, Harry G, Wolfert, Robert L, Woodrum, David L

Get full text

Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis by Partin, Alan W, Catalona, William J, Finlay, Judith A, Darte, Claude, Tindall, Donald J, Young, Charles Y.-F, Klee, George G, Chan, Daniel W, Rittenhouse, Harry G, Wolfert, Robert L, Woodrum, David L

Get full text

Human Kallikrein 2 (hK2) and Prostate-Specific Antigen (PSA): Two Closely Related, but Distinct, Kallikreins in the Prostate by Rittenhouse, Harry G., Finlay, Judith A., Mikolajczyk, Stephen D., Partin, Alan W.

Get full text

Standardization of Two Immunoassays for Human Glandular Kallikrein 2 by Haese, Alexander, Vaisanen, Ville, Finlay, Judith A, Pettersson, Kim, Rittenhouse, Harry G, Partin, Alan W, Bruzek, Debra J, Sokoll, Lori J, Lilja, Hans, Chan, Daniel W

Get full text

pp32 by Williams, Timothy K, Costantino, Christina L, Bildzukewicz, Nikolai A, Richards, Nathan G, Rittenhouse, David W, Einstein, Lisa, Cozzitorto, Joseph A, Keen, Judith C, Dasgupta, Abhijit, Gorospe, Myriam, Gonye, Gregory E, Yeo, Charles J, Witkiewicz, Agnieszka K, Brody, Jonathan R

Get full text

Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer by Pannek, Jürgen, Rittenhouse, Harry G., Evans, Cindy L., Finlay, Judith A., Bruzek, Debra J., Cox, Jennifer L., Chan, Daniel W., Subong, Eric N.P., Partin, Alan W.

Get full text

Inhibitor stabilization of human immunodeficiency virus type-2 proteinase dimer formation by HOLZMAN, T. F, KOHLBRENNER, W. E, WEIGL, D, RITTENHOUSE, J, KEMPF, D, ERICKSON, J

Get full text